Efficacy News and Research

RSS
Review and case study illustrates the challenges of monkeypox

Review and case study illustrates the challenges of monkeypox

Investigating PREVENT-19 trial findings of serological correlates of immune protection and risk against COVID-19

Investigating PREVENT-19 trial findings of serological correlates of immune protection and risk against COVID-19

Antigenic differences between early SARS-CoV-2 variants

Antigenic differences between early SARS-CoV-2 variants

LUCID: music, medicine, and machine learning

LUCID: music, medicine, and machine learning

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

Five things to know now that the Supreme Court has overturned Roe V. Wade

Five things to know now that the Supreme Court has overturned Roe V. Wade

Updated Cochrane Review: No evidence to support the use of ivermectin for treating COVID-19 infection

Updated Cochrane Review: No evidence to support the use of ivermectin for treating COVID-19 infection

Scientists develop suitable human cell line for anti-SARS-CoV-2 drug screening

Scientists develop suitable human cell line for anti-SARS-CoV-2 drug screening

Associations between maternal COVID-19 vaccination and hospitalization among infants

Associations between maternal COVID-19 vaccination and hospitalization among infants

New nanoparticles effectively stopped the growth and spread of ovarian, liver tumors in mice

New nanoparticles effectively stopped the growth and spread of ovarian, liver tumors in mice

Fragment crystallizable-altered COVID-19 antibodies efficacious across two animal models

Fragment crystallizable-altered COVID-19 antibodies efficacious across two animal models

Researchers continue a national study to evaluate COVID-19 vaccination safety pre-and post-delivery

Researchers continue a national study to evaluate COVID-19 vaccination safety pre-and post-delivery

Addressing parents' hesitancy to vaccinate their children against COVID

Addressing parents' hesitancy to vaccinate their children against COVID

Correlates of anamnestic humoral immunity throughout SARS-CoV-2 variants of concern

Correlates of anamnestic humoral immunity throughout SARS-CoV-2 variants of concern

Research assesses ability of SARS‐CoV‐2‐neutralising mAbs to prevent COVID‐19

Research assesses ability of SARS‐CoV‐2‐neutralising mAbs to prevent COVID‐19

Analyzing biophysical restrictions of SARS-CoV-2 N-terminal domain

Analyzing biophysical restrictions of SARS-CoV-2 N-terminal domain

Lung cancer patients treated with immune checkpoint inhibitors can be safely vaccinated against COVID-19, study says

Lung cancer patients treated with immune checkpoint inhibitors can be safely vaccinated against COVID-19, study says

RUDN doctors propose an alternative method of surgical management of glaucoma

RUDN doctors propose an alternative method of surgical management of glaucoma

Preclinical study unlocks the promise of CAR T-cell therapy for treatment of solid tumors

Preclinical study unlocks the promise of CAR T-cell therapy for treatment of solid tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.